Regulatory Reform Could Elevate Value-Added Medicines To Their ‘Rightful Place’, Says Narayan
Medicines For Europe Says EU Should Foster Patients Access To VAMs
Medicines for Europe is calling on the EU to recognize value-added medicines as its own separate group in its pharmaceutical legislation.